ERR-gamma could be new target for obesity drugs

14 Mar 2018


Researchers have identified how the oestrogen-related receptor gamma (EER-gamma) gives brown fat its energy-burning identity, which could lead to new obesity drug targets, according to a study in Cell Reports.

Medical Xpress

 


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story